Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 31 | $1,356,323 |
Sells | 240 | $369,781,629 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jun 2024 16:15 | NYC | American Strategic Investment Co. | RADESCA NICHOLAS | Director | 24 Jun 2024 | Purchase | 2,500 | 9.0417 | 22,604 | D |
26 Jun 2024 17:10 | LOCL | Local Bounti Corp | NELSON MARK JOSEPH | Director | 25 Jun 2024 | Sale | 8,405 | 2.6808 | 22,532 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 96 | 228.3 | 21,917 | D |
26 Jun 2024 16:25 | UPST | Upstart Holdings Inc | DATTA SANJAY | Chief Financial Officer | 24 Jun 2024 | Sale | 1,000 | 21.68 | 21,680 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 93 | 225.55 | 20,976 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 86 | 233.53 | 20,084 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 78 | 221.71 | 17,293 | D |
26 Jun 2024 16:50 | AMWL | American Well Corp | JACKSON DEBORAH C | Director | 24 Jun 2024 | Sale | 42,202 | 0.4072 | 17,185 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 74 | 231.59 | 17,138 | D |
26 Jun 2024 17:12 | QS | QuantumScape Corp | HETTRICH KEVIN | CHIEF FINANCIAL OFFICER | 24 Jun 2024 | Sale | 3,300 | 5.0052 | 16,517 | D |
26 Jun 2024 16:54 | NUVL | Nuvalent Inc | SHAIR MATTHEW | Director | 24 Jun 2024 | Sale | 190 | 80.98 | 15,386 | I |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 66 | 224.17 | 14,795 | D |
26 Jun 2024 16:57 | HTGC | Hercules Capital Inc | CROWELL GAYLE A | Director | 25 Jun 2024 | Purchase | 701.6 | 20.0499 | 14,067 | D |
26 Jun 2024 13:46 | FXNC | FIRST NATIONAL CORP | WILKINS III JAMES R | Director | 25 Jun 2024 | Purchase | 886 | 14.95 | 13,246 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 25 Jun 2024 | Sale | 100 | 126.461 | 12,646 | D |
26 Jun 2024 17:10 | LOCL | Local Bounti Corp | NELSON MARK JOSEPH | Director | 24 Jun 2024 | Sale | 3,695 | 2.886 | 10,664 | D |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 24 Jun 2024 | Purchase | 7,208 | 1.44 | 10,380 | I |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 45 | 226.82 | 10,207 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 45 | 221.71 | 9,977 | D |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 25 Jun 2024 | Purchase | 6,685 | 1.45 | 9,693 | I |
26 Jun 2024 15:17 | ADMQ | ADM ENDEAVORS Inc | JOHNSON MARC | CEO | 25 Jun 2024 | Purchase | 200,000 | 0.0472 | 9,440 | D |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | FARQUHAR SCOTT | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 50 | 168.14 | 8,407 | I |
26 Jun 2024 17:28 | TEAM | Atlassian Corp | CANNON-BROOKES MICHAEL | Co-CEO, Co-Founder, 10% | 25 Jun 2024 | Sale | 50 | 168.14 | 8,407 | I |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 24 Jun 2024 | Sale | 200 | 39 | 7,800 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:15 | OBIO | Orchestra BioMed Holdings Inc | HOCHMAN DAVID P | See Remarks | 25 Jun 2024 | Purchase | 1,000 | 6.95 | 6,950 | I |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 26 | 226.82 | 5,897 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 24 | 225.55 | 5,413 | D |
26 Jun 2024 16:38 | ORGN | Origin Materials Inc | HEIDENMARK COOK PIA JOHANNA | Director | 25 Jun 2024 | Sale | 4,640 | 0.9844 | 4,568 | D |
26 Jun 2024 16:46 | NABL | N-able Inc | PAI KATHLEEN | EVP, Chief People Officer | 25 Jun 2024 | Sale | 300 | 15 | 4,500 | D |
26 Jun 2024 17:01 | NOTE | FiscalNote Holdings Inc | YAO GERALD | CSO and Director | 24 Jun 2024 | Sale | 2,750 | 1.5 | 4,125 | I |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 17:37 | PPTINC | Presidio Property Trust Inc | HEILBRON JACK KENDRICK | Chief Executive Officer | 26 Jun 2024 | Purchase | 6,000 | 0.6401 | 3,841 | D |
26 Jun 2024 17:37 | PPTINC | Presidio Property Trust Inc | HEILBRON JACK KENDRICK | Chief Executive Officer | 25 Jun 2024 | Purchase | 6,000 | 0.64 | 3,840 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 17 | 224.17 | 3,811 | D |
26 Jun 2024 14:29 | UHAL | U-Haul Holding Co | HERRERA RICHARD JAY | Director | 09 Nov 2021 | Purchase | 5 | 752.19 | 3,761 | I |
26 Jun 2024 14:29 | UHAL | U-Haul Holding Co | HERRERA RICHARD JAY | Director | 02 Nov 2021 | Purchase | 5 | 744.95 | 3,725 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 23 | 161.27 | 3,709 | D |
26 Jun 2024 17:06 | OB | Outbrain Inc | GALAI YARON | Director | 24 Jun 2024 | Sale | 700 | 4.95 | 3,465 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 13 | 225.55 | 2,932 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 24 Jun 2024 | Purchase | 742 | 3.2 | 2,374 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 9 | 224.17 | 2,018 | D |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 25 Jun 2024 | Sale | 1,214 | 1.4 | 1,700 | D |
26 Jun 2024 16:11 | ULY | Urgent.ly Inc | BEN VOLKOW | Director | 24 Jun 2024 | Sale | 1,000 | 1.6505 | 1,650 | D |
26 Jun 2024 17:06 | OB | Outbrain Inc | GALAI YARON | Director | 25 Jun 2024 | Sale | 277 | 4.95 | 1,371 | D |
26 Jun 2024 16:11 | ULY | Urgent.ly Inc | BEN VOLKOW | Director | 25 Jun 2024 | Sale | 800 | 1.5503 | 1,240 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 200 | 3.2 | 640 | D |
26 Jun 2024 16:15 | SPXC | SPX Technologies Inc | DATA J RANDALL | PRES., HEATING AND GLOBAL OPER | 24 Jun 2024 | Sale | 4 | 144.84 | 579 | D |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | SULLIVAN LYNNE MARIE | CFO & Head of Corp. Dev. | 25 Jun 2024 | Sale | 324 | 1.4 | 454 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 26 Jun 2024 | Purchase | 104 | 4.25 | 442 | D |
26 Jun 2024 15:17 | ADMQ | ADM ENDEAVORS Inc | JOHNSON MARC | CEO | 25 Jun 2024 | Purchase | 10,000 | 0.042 | 420 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 107 | 3.75 | 401 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 100 | 4 | 400 | D |
26 Jun 2024 17:36 | SSII | SS Innovations International Inc | COHEN BARRY F | COO - Americas | 25 Jun 2024 | Purchase | 100 | 3.5 | 350 | D |
26 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 24 Jun 2024 | Sale | 2 | 161.1 | 322 | D |
26 Jun 2024 16:17 | HOV | HOVNANIAN ENTERPRISES INC | HOVNANIAN ARA K | Chairman of Bd., Pres. & CEO, 10% | 24 Jun 2024 | Sale | 2 | 148.305 | 297 | D |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 78 | 1.65 | 129 | I |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 72 | 1.65 | 119 | I |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | Chief Legal Officer | 25 Jun 2024 | Sale | 78 | 1.4 | 109 | D |
26 Jun 2024 16:30 | VSTM | Verastem Inc | CALKINS DANIEL | Chief Financial Officer | 24 Jun 2024 | Sale | 28 | 3.15 | 88 | D |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 18 | 1.65 | 30 | I |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 14 | 1.65 | 23 | D |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 1 | 1.65 | 2 | I |
26 Jun 2024 11:38 | RCG | RENN Fund Inc | STAHL MURRAY | President and CEO | 25 Jun 2024 | Purchase | 1 | 1.65 | 2 | I |
26 Jun 2024 16:30 | PIII | P3 Health Partners Inc | LEAVITT LEGACY, LLC | 10% | 24 May 2024 | Purchase | 7,974,481 | 0 | 0 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)